William Richardson, MD
Orthopaedic Surgery · Durham, NCNPI 1831286475
Payments from drug & device makers
Across 111 payments — averaging $724.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$47K
- Pfizer$23K
- Brainlab, Inc.$6K
- Globus Medical$2K
- Medtronic$456
- Medicrea USA, Corp.$420
- plus $1K from 10 others
What the payments were for
- Consulting fees$40,75070%
- Speaking & faculty fees$2,8115%
- Travel & lodging$10,94019%
- Food & beverage$3,3286%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 49 | $47,150 |
| Pfizer | 6 | $22,554 |
| Brainlab, Inc. | 13 | $6,322 |
| Globus Medical | 11 | $2,068 |
| Medtronic(2 entities) | 7 | $456 |
| Medicrea USA, Corp. | 2 | $420 |
| Amgen | 5 | $298 |
| Bioventus LLC | 3 | $196 |
| Johnson & Johnson | 6 | $189 |
| Exactech, Inc. | 1 | $164 |
| Medical Device Business Services, Inc. | 3 | $156 |
| Si-bone, Inc. | 1 | $155 |
| Zimmer Biomet | 1 | $89 |
| Cerapedics Inc. | 1 | $82 |
| Innovation Technologies Inc | 1 | $72 |
| MML US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRO$28,825
- AIRO TRUCT$8,000
- MANTIS$4,250
- Excelsius - GPS$1,899
- NEW PRODUCT DEVELOPMENT$1,325
- PASS-LP$420
- UNiD$420
- EQUINOXE$164
- O-ARM-ST$155
- EVENITY$141
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$125
How this compares
$80,382 in reported general payments places this provider in the 85th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 270 | $2,701 |
| Oxycodone Hcl | 48 | $715 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $540 |
| Pregabalin | 14 | $134 |
| Methylprednisolone | 12 | $68 |
| Tramadol Hcl | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Durham
- William JiranekDurham$6.4M
- Thomas VailDurham$5.7M
- Mark EasleyDurham$4.2M
- Samuel AdamsDurham$3.3M
- Michael BolognesiDurham$2.5M
- Christopher BrownDurham$2.3M
- David MusanteDurham$2.2M
- James NunleyDurham$1.7M
- Samuel WellmanDurham$1.3M
- James DeorioDurham$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.